Italia markets closed

BMY Jan 2026 65.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,1100+0,0300 (+2,78%)
Alla chiusura: 10:32AM EDT
Schermo intero
Chiusura precedente1,0800
Aperto1,1100
Denaro1,0000
Lettera1,0700
Prezzo d'esercizio65,00
Scadenza2026-01-16
Min-Max giorno1,1100 - 1,1100
Contratto - Min-MaxN/D
Volume3
Open Interest676
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri